|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Leukemia | |||||
| Myelodysplastic Syndromes | |||||
| Sarcoma | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Preleukemia | |||||
| Rhabdomyosarcoma | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Bone Marrow Diseases | |||||
| Disease | |||||
| Hematologic Diseases | |||||
| Myosarcoma | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms, Connective and Soft Tissue | |||||
| Neoplasms, Muscle Tissue | |||||
| Pathologic Processes | |||||
| Precancerous Conditions | |||||
| 4 | Interventions listed in this trial | ||||
| clonality analysis | |||||
| microsatellite instability analysis | |||||
| mutation analysis | |||||
| 5 | Sponsors listed in this trial | ||||
| Children's Oncology Group | |||||
| National Cancer Institute (NCI) | |||||